Ondřej Sedláček

Poly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?

Ondřej Sedláček, Bryn D. Monnery, Sergey K. Filippov et al. · Macromolecular Rapid Communications · 2012 · 310 citations

Natural Sciences, Bioengineering, Materials Science +16

Drug Delivery Systems Based on Poly(2‐Oxazoline)s and Poly(2‐Oxazine)s

Ondřej Sedláček, Richard Hoogenboom · Advanced Therapeutics · 2019 · 134 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues

Ondřej Sedláček, Bryn D. Monnery, Jana Mattová et al. · Biomaterials · 2017 · 106 citations

Medicine, Oncology, Pharmacology +12

Defined High Molar Mass Poly(2‐Oxazoline)s

Bryn D. Monnery, Valentin Victor Jerca, Ondřej Sedláček et al. · Angewandte Chemie International Edition · 2018 · 82 citations · Full text

Natural Sciences, Chemistry, Materials Science +17

A simple neridronate-based surface coating strategy for upconversion nanoparticles: highly colloidally stable¹²⁵I-radiolabeled NaYF₄:Yb³⁺/Er³⁺@PEG nanoparticles for multimodal<i>in vivo</i>tissue imaging

Uliana Kostiv, Volodymyr Lobaz, Jan Kučka et al. · Nanoscale · 2017 · 77 citations · Full text

Natural Sciences, Biomedical Engineering, Materials Science +16